Skip to content
WeighLab
Menu
Ranked #352 · Grade C

WeightCare review

WeightCare sells compounded semaglutide and tirzepatide through 'FDA-registered and PCAB-accredited compounding pharmacies' (unnamed) at a genuine month-to-month rate of $399 and $499.

Visit WeightCare Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
$399/mo (all doses, compounded)
Tirzepatide
$499/mo (all doses, prepay plan, compounded)
Coverage
Coverage not published
Brand-name
Compounded only

Semaglutide · modeled / year

$4,788

Tirzepatide · modeled / year

$5,988

Pricing verified August 2026

The Index scorecard

WeightCare scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month36/100
Price Transparency94/100
Nationwide Access24/100
Formulation Options66/100
Clinical Oversight75/100
Contract Flexibility33/100

Where the value is

  • True month-to-month plans exist with no prepay commitment, covering the full published dose range for both drugs
  • PCAB-accredited, FDA-registered compounding pharmacies explicitly claimed (industry-recognized quality signal, though the specific pharmacy is not named)
  • Cancellation requires only 7-day notice before renewal
  • Both semaglutide and tirzepatide offered, plus separate microdosing product lines for each

The tradeoffs

  • The cheapest advertised per-month prices ($215 sema, $275 tirz) require a full 6-month prepay ($1,290 / $1,650 up front) and cap you below the drug's top dose — going higher costs more via a separate High Dose plan
  • No LegitScript certification found anywhere on the site
  • No named medical director, prescriber, or specific compounding pharmacy — only the generic PCAB/FDA-registered claim
  • No legal entity name or physical address disclosed
  • FDA issued Weightless Medical LLC dba WeightCare a warning letter in February 2026; the letter is public in FDA's warning-letter database

The bottom line

Best for: Cost-first shoppers who want a genuine month-to-month plan covering the full dose range, without a multi-month prepay commitment. WeightCare sells compounded semaglutide and tirzepatide through 'FDA-registered and PCAB-accredited compounding pharmacies' (unnamed) at a genuine month-to-month rate of $399 and $499.

Ranked #352 of 539 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 538 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to WeightCare.

The 18 programs nearest this one

Pricing, states and verification reflect WeightCare's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on WeightCare's site. Not medical advice; see our disclosure.

← Back to the value leaderboard